Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 1998

View Archived Issues

Leprovac: the first commercially available leprosy vaccine

Abciximab treatment validated for prevention of ischemic complications after coronary intervention

Moxifloxacin: possible treatment for S. pneumoniae meningitis

Sheffield and Elan finalize pulmonary drug delivery collaboration

CGP-56697 found to be a safe treatment for uncomplicated falciparum malaria in children

New hope for eliminating mother-to-child transmission of HIV

RADARS study establishes efficacy and safety of Diastat

Millennium, Wyeth-Ayerst discover gene target for CNS disorders

Profile of Lilly's LY-333334, a biosynthetic PTH for inducing bone regeneration

Iomed and Novartis to discontinue research collaboration

RS-980400: a bone-selective vitamin D analogue with bone anabolic effects

Japanese investigators study HIV protease inhibitor with activity in drug-resistant virus

Lodenosine phase I data supports combination studies

Caspase inhibitors in development at Warner-Lambert

Adenosine derivatives useful for CNS and cardiovascular disorders

Immunosuppressive potassium channel blockers from Merck & Co.

Cor Therapeutics patents novel factor Xa inhibitors

Compounds for dopaminergic disorders discovered at American Home Products

AMD-3465, a selective CXCR4 antagonist with potent anti-HIV activity

Bone-sparing antiinflammatory benzamide under investigation at Daiichi

Fujisawa identifies novel ACAT inhibitor series, selects development candidate

MX-68: mechanisms underlying antiinflammatory activity

New peristaltic stimulant on the way to market in Japan

Mechanism of action of new antiarthritic drug KE-298

Clinical trial results in RA reported for T-614

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...